Filtered By:
Specialty: Cardiology
Condition: Hypertension
Therapy: Dialysis

This page shows you your search results in order of date.

Order by Relevance | Date

Total 19 results found since Jan 2013.

Mediacalcosis in hemodialysis, predictors and prognosis
ConclusionMediacalcosis is a severe complication since it increases the risk of cardiovascular morbidity and mortality in hemodialysis patients, to this end, the individualization of entangled factors involved in its pathophysiology, will slow down or prevent its progression in the future.
Source: Archives of Cardiovascular Diseases Supplements - July 24, 2019 Category: Cardiology Source Type: research

Cardiac complications in children with chronic renal: Prevalence of risk factors
ConclusionCardiovascular complications are almost constant in hemodialysis children with chronic renal failure strongly related with left ventricular hypertrophy and arterial hypertension. The high risk of mortality related to these cardiac complications makes it essential to have good control of arterial blood pressure and especially a good observance of treatment and regimen in hemodialysis children.
Source: Archives of Cardiovascular Diseases Supplements - July 24, 2019 Category: Cardiology Source Type: research

Difficulty of stroke management in the dialysis child
ConclusionCause or consequences of the renal disease, HT must be properly treated in order to reach the recommended targeted blood pressure values. The time required to take charge the hypertensive stroke determines the prognosis. The challenge is to optimize the health care sector to reduce mortality and sequelae.
Source: Archives of Cardiovascular Diseases Supplements - July 24, 2019 Category: Cardiology Source Type: research

Effect of Warfarin on Ischemic Stroke, Bleeding, and Mortality in Patients with Atrial Fibrillation Receiving Peritoneal Dialysis
ConclusionThere is no significant association between warfarin treatment with risks of mortality, ischemic stroke or bleeding in patients with atrial fibrillation receiving peritoneal dialysis.
Source: American Journal of Cardiovascular Drugs - April 22, 2019 Category: Cardiology Source Type: research

Abstract P438: Cardio-Renal Anemia Syndrome in acute heart failure patients: An Observational data from “Gulf-CARE” Heart Failure Registry Session Title: Chronic Kidney Disease
Conclusions: In the setting of acute heart failure in CRAS patients LV function has no significant role in the incidence of in-hospital stroke, major bleeding and death.
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Mohammed Al Jarallah, Rajesh Rajan, Ahmed R. Al-Saber, Raja Dashti, Bassam Bulbanat, Mustafa Ridha, Khadhim Sulaiman, Prashanth Panduranga, Alawi Alshekh-Ali, Khalid Al Habib, Jassim Al Suwaidi, Wael Al Mahmeed, Hussam Al Faleh, Abdelfatah Elasfar, Ahmed Tags: Poster Abstract Presentations Source Type: research

Blood Pressure and Risk of Cardiovascular Events in Patients on Chronic HemodialysisNovelty and Significance Dialysis and Blood Pressure
In conclusion, among hemodialysis patients, although there is a U-shaped (paradoxical) association of dialysis-unit-SBP and risk of cardiovascular disease, there is a linear association of out-of-dialysis-unit-SBP with risk of cardiovascular disease. Out-of-dialysis-unit blood pressure provides key information and may be an important therapeutic target.
Source: Hypertension - July 12, 2017 Category: Cardiology Authors: Nisha Bansal, Charles E. McCulloch, Feng Lin, Arnold Alper, Amanda H. Anderson, Magda Cuevas, Alan S. Go, Radhakrishna Kallem, John W. Kusek, Claudia M. Lora, Eva Lustigova, Akinlolu Ojo, Mahboob Rahman, Cassianne Robinson-Cohen, Raymond R. Townsend, Jack Tags: Epidemiology, Cardiorenal Syndrome Original Articles Source Type: research

Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males.
CONCLUSIONS: These results suggest that the hypertension and hyperglycemia and their combination may be associated with the incidence of CKD. PMID: 28590145 [PubMed - as supplied by publisher]
Source: Clinical and Experimental Hypertension - June 7, 2017 Category: Cardiology Authors: Michishita R, Matsuda T, Kawakami S, Tanaka S, Kiyonaga A, Tanaka H, Morito N, Higaki Y Tags: Clin Exp Hypertens Source Type: research

Abstract 171: Improving Adherence to Antihypertensive Agents for Hypertensive Patient With Chronic Kidney Disease Session Title: Poster Session II
Conclusions: Good MA is associated with a greater controlled hypertension, better protection of heart and kidney and may decrease mortality than the poor MA.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Li, Y., Zeng, X., Zeng, X., Xie, J. Tags: Session Title: Poster Session II Source Type: research

Visit-to-visit blood pressure variability is a risk factor for all-cause mortality and cardiovascular disease: a systematic review and meta-analysis
Conclusion: In summary, among the wide heterogenetic population, modest associations between VVV of SBP and all-cause mortality, CVD incidence, CVD mortality, CHD incidence, and stroke incidence were found. Findings of the current study suggested that standardized approaches of monitoring VVV in the high-risk population, including patients with cardiac infarction, diabetes, stroke, and patients with chronic kidney disease or in dialysis, are necessary in designing a prospective clinical study on the association of VVV and patients’ prognosis.
Source: Journal of Hypertension - December 1, 2016 Category: Cardiology Tags: Reviews Source Type: research

Soluble Guanylate Cyclase Stimulators: a Novel Treatment Option for Heart Failure Associated with Cardiorenal Syndromes?
Abstract Heart failure in the setting of chronic kidney disease (CKD) is an increasingly common scenario and carries a poor prognosis. Clinicians lack tools for primary or secondary heart failure prevention in patients with cardiorenal syndromes. In patients without CKD, angiotensin-converting enzyme inhibitors (ACE-I) or angiotensin receptor blockers (ARB) and statins mitigate cardiovascular risk in large part due to salutary effects on the endothelium. In the setting of CKD, use of these therapies is limited by adverse effects of hyperkalemia in pre-dialysis CKD (ACE-I/ARB), or potential increased risk of stroke...
Source: Current Heart Failure Reports - April 26, 2016 Category: Cardiology Source Type: research

Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2
<span class="paragraphSection">The choice of oral anticoagulant (OAC) for patients with atrial fibrillation (AF) may be influenced by individual clinical features or by patterns of risk factors and comorbidities. We reviewed analyses of subgroups of patients from trials of vitamin K antagonists vs. non-vitamin K oral anticoagulants (NOACs) for stroke prevention in AF with the aim to identify patient groups who might benefit from a particular OAC more than from another. In addition, we discuss the timing of initiation of anticoagulation. In the second of a two-part review, we discuss the use of NOAC for stroke prevent...
Source: European Heart Journal - February 4, 2016 Category: Cardiology Source Type: research

Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease
Conclusion: Higher VVV of BP is independently associated with higher rates of death and hemorrhagic stroke in patients with moderate to advanced CKD not yet on dialysis.
Source: Journal of Hypertension - December 23, 2015 Category: Cardiology Tags: ORIGINAL PAPERS: BP measurement Source Type: research

Randomized Controlled Trials of Blood Pressure Lowering in Hypertension: A Critical Reappraisal.
Abstract Sixty-eight blood pressure (BP)-lowering randomized controlled trials (defined as randomized controlled trials comparing active treatment with placebo, or less active treatment, achieving a BP difference, performed between 1966 and end 2013 in cohorts with ≥40% hypertensive patients, and exclusive of trials in acute myocardial infarction, heart failure, acute stroke, and dialysis) were identified and meta-analyzed grouping the randomized controlled trials on the basis of clinically relevant questions: (1) does BP lowering reduce all types of cardiovascular outcome? (2) Is prevention of all outcomes prop...
Source: Circulation Research - March 13, 2015 Category: Cardiology Authors: Zanchetti A, Thomopoulos C, Parati G Tags: Circ Res Source Type: research

Non Invasive Evaluation of Cardiac Hemodynamics in End Stage Renal Disease (ESRD)
Conclusions Blood pressure, cardiac morphology and function are significantly modified by acute volume depletion and such variations are strictly interrelated. SW and LVEDd/height2.7 may identify ESRD patients carrying an higher volume load.
Source: High Blood Pressure and Cardiovascular Prevention - November 19, 2014 Category: Cardiology Source Type: research

Effects of blood pressure lowering on outcome incidence in hypertension. 1. Overview, meta-analyses, and meta-regression analyses of randomized trials
Background:Antihypertensive treatment is based on randomized controlled trials (RCTs) started since 1966. Meta-analyses comprehensive of all RCTs but limited to RCTs investigating blood pressure (BP) lowering in hypertensive patients are lacking. Objectives:Two clinical questions were investigated: the extent of different outcome reductions by BP lowering in hypertensive patients, and the proportionality of outcome reductions to SBP, DBP, and pulse pressure (PP) reductions. Methods:PubMed between 1966 and December 2013 (any language), Cochrane Collaboration Library and previous overviews were used as data sources for ident...
Source: Journal of Hypertension - November 10, 2014 Category: Cardiology Tags: Reviews Source Type: research